For their growth and survival, cancer cells also rely on their glucose metabolism in order to obtain ATP molecules, and this process demands a greater supply of glucose that is mediated mainly by the GLUT1 transmembrane transporters [11], that represents the molecular basis for radiolabeled glucose, used in FDG-PET. Here, SLC2A1 is linked to cancer.